These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9646102)

  • 1. Transplant vasculopathy.
    Deng MC; Tjan TD; Asfour B; Roeder N; Scheld HH
    Herz; 1998 May; 23(3):197-201. PubMed ID: 9646102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia.
    Aziz S; McDonald TO; Gohra H
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant vasculopathy: a model for coronary artery disease?
    Deng MC; Plenz G; Erren M; Wilhelm MJ; Moennig G; Rothenburger M; Baba HA
    Herz; 2000 Mar; 25(2):95-9. PubMed ID: 10829247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response.
    Hosenpud JD; Morris TE; Shipley GD; Mauck KA; Wagner CR
    Transplantation; 1996 Mar; 61(6):939-48. PubMed ID: 8623164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy.
    Vassalli G; Gallino A; Weis M; von Scheidt W; Kappenberger L; von Segesser LK; Goy JJ;
    Eur Heart J; 2003 Jul; 24(13):1180-8. PubMed ID: 12831811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody deposition in rat heart which develops transplant vasculopathy in (donor x recipient) F1 environment.
    Li Z; Kitagawa-Sakakida S; Horiguchi K; Tori M; Shirakura R
    Surg Today; 2003; 33(7):509-17. PubMed ID: 14506995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.
    Rose ML
    J Heart Lung Transplant; 1996 Apr; 15(4):342-9. PubMed ID: 8732592
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of transplant vasculopathy].
    Baron H; Plenz G; Deng MC
    Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy.
    Hosenpud JD; Everett JP; Morris TE; Wagner CR; Shipley GD
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S185-7. PubMed ID: 8719483
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
    Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
    Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis.
    Hillebrands J; van den Hurk BM; Klatter FA; Popa ER; Nieuwenhuis P; Rozing J
    J Heart Lung Transplant; 2000 Dec; 19(12):1183-92. PubMed ID: 11124488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease.
    Kaufman C; Zeevi A; Zerbe T; Keenan R; Kormos R; Griffith B; Hardesty R; Armitage J; Uretsky B; Duquesnoy RJ
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1142-3. PubMed ID: 1989172
    [No Abstract]   [Full Text] [Related]  

  • 14. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
    Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
    Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines and transplant vasculopathy.
    Belperio JA; Ardehali A
    Circ Res; 2008 Aug; 103(5):454-66. PubMed ID: 18757833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune mechanisms of cardiac allograft vasculopathy: an update.
    Hosenpud JD
    Transpl Immunol; 1993; 1(4):237-49. PubMed ID: 8081780
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide.
    Koglin J
    Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense Cdc2 kinase oligonucleotide inhibits adhesion molecule expression in cardiac allograft arteriopathy.
    Suzuki J; Izawa A; Morishita R; Kaneda Y; Sawa Y; Okubo Y; Ogihara T; Sekiguchi M; Isobe M
    Transplant Proc; 1999; 31(1-2):955-6. PubMed ID: 10083423
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic rejection in the heart.
    Hornick P; Rose M
    Methods Mol Biol; 2006; 333():131-44. PubMed ID: 16790849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft vasculopathy--the cellular attack.
    Hutchinson IV
    Z Kardiol; 2000; 89 Suppl 9():IX/16-20. PubMed ID: 11151784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.